The government of Singapore is currently assessing the potential implementation of chemical castration, formally referred to as pharmacological anti-androgen treatment, as a strategy to address sex-related offenses. Officials have clarified that the adoption of such measures is not currently active policy but remains a subject of consideration.

The core of the government's position is contingent upon empirical data. Authorities have indicated that they would only move forward with this intervention if there is clear, verifiable evidence that such treatments successfully reduce the rate of reoffending among sex criminals. This approach reflects a broader ongoing debate regarding the balance between public safety initiatives and the ethical implications of medical interventions in the criminal justice system.

While the proposal has surfaced in public discourse, the government has emphasized a cautious, evidence-based approach. There is currently no definitive timeline for a policy change, nor has the government released specific details regarding which categories of offenders might be targeted or the legal framework that would govern such a program. The discussion remains in the preliminary stages, with the primary focus being whether the medical suppression of testosterone can serve as an effective deterrent against future sexual violence.